Novelties in the pharmacological approaches for chronic heart failure: new drugs and cardiovascular targets

被引：7

作者：

Correale, Michele ^{[1
]}

Tricarico, Lucia ^{[1
]}

Croella, Francesca ^{[2
]}

Alfieri, Simona ^{[2
]}

Fioretti, Francesco ^{[3
]}

Brunetti, Natale Daniele ^{[2
]}

Inciardi, Riccardo M. ^{[3
]}

Nodari, Savina ^{[3
]}

机构：

[1] Policlin Riuniti Univ Hosp, Dept Cardiothorac, Foggia, Italy

[2] Univ Foggia, Dept Med & Surg Sci, Foggia, Italy

[3] Univ Brescia, ASST Spedali Civili Hosp, Dept Med & Surg Specialties, Cardiol Sect, Brescia, Italy

来源：

FRONTIERS IN CARDIOVASCULAR MEDICINE | 2023年 / 10卷

关键词：

new drugs; therapy targets; heart failure; cardiac metabolism; mitochondrial function; CGMP pathway; SOLUBLE GUANYLATE-CYCLASE; REDUCED EJECTION FRACTION; FATTY-ACID OXIDATION; LEFT-VENTRICULAR HYPERTROPHY; RANDOMIZED CONTROLLED-TRIAL; COTRANSPORTER; INHIBITION; DOUBLE-BLIND; METABOLIC MODULATOR; CLINICAL-TRIAL; NATRIURETIC PEPTIDE;

D O I：

10.3389/fcvm.2023.1157472

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Despite recent advances in chronic heart failure (HF) management, the prognosis of HF patients is poor. This highlights the need for researching new drugs targeting, beyond neurohumoral and hemodynamic modulation approach, such as cardiomyocyte metabolism, myocardial interstitium, intracellular regulation and NO-sGC pathway. In this review we report main novelties on new possible pharmacological targets for HF therapy, mainly on new drugs acting on cardiac metabolism, GCs-cGMP pathway, mitochondrial function and intracellular calcium dysregulation.

引用

页数：19

共 50 条

[31] Editorial: Cardio-Protection and Heart Repair: New Drugs, Targets and Approaches
Zagidullin, Naufal
Cai, Benzhi
Zhu, Hua
FRONTIERS IN PHARMACOLOGY, 2021, 12
[32] IN SILICO SCREENING OF SOME OLD DRUGS FOR NEW APPROACHES IN HEART FAILURE
Sava, A.
Profire, Bianca Stefania
Lupascu, Florentina
Profire, Lenuta
MEDICAL-SURGICAL JOURNAL-REVISTA MEDICO-CHIRURGICALA, 2023, 127 (03): : 488 - 496
[33] New approaches in the management of patients with chronic congestive heart failure
Jessup, M
Brozena, S
DRUGS OF TODAY, 1999, 35 (11) : 849 - 855
[34] Review of the new ESC guidelines for the pharmacological management of chronic heart failure
Maggioni, AP
EUROPEAN HEART JOURNAL SUPPLEMENTS, 2005, 7 (0J) : J15 - J20
[35] New Developments in Cardiovascular Drugs: Heart Failure—An Informal and Personal Viewpoint
Lionel H. Opie
Cardiovascular Drugs and Therapy, 1997, 11 : 519 - 520
[36] Current Clinical and Pharmacological Approaches to the Prescription of Loop Diuretics in Patients with Chronic Heart Failure
Gafurova, Nupaysat M.
Shikh, Evgenia, V
Ostroumova, Olga D.
RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2020, 16 (04) : 595 - 600
[37] New developments in cardiovascular drugs: Heart failure - An informed and personal viewpoint
Opie, LH
CARDIOVASCULAR DRUGS AND THERAPY, 1997, 11 (04) : 519 - 520
[38] Prescription of cardiovascular drugs in the French ODIN cohort of heart failure patients according to age and type of chronic heart failure
Juilliere, Yves
Suty-Selton, Christine
Riant, Elisabeth
Darracq, Jean-Pierre
Dellinger, Arnaud
Labarre, Jean-Philippe
Druelle, Justine
Mulak, Genevieve
Danchin, Nicolas
Jourdain, Patrick
ARCHIVES OF CARDIOVASCULAR DISEASES, 2014, 107 (01) : 21 - 32
[39] PHARMACOLOGICAL TREATMENT OF HEART-FAILURE WITH STANDARD DRUGS
PITT, B
CURRENT OPINION IN CARDIOLOGY, 1994, 9 (03) : 289 - 294
[40] Pharmacological targets of drugs employed in chronic venous and lymphatic insufficiency
Boisseau, MR
INTERNATIONAL ANGIOLOGY, 2002, 21 (02) : 33 - 39

← 1 2 3 4 5 →